2016
DOI: 10.1016/j.mrrev.2016.03.005
|View full text |Cite
|
Sign up to set email alerts
|

The many faces of histone H3K79 methylation

Abstract: Dot1/DOT1L (disruptor of telomeric silencing-1) is an evolutionarily conserved histone methyltransferase that methylates lysine 79 located within the globular domain of histone H3. Dot1 was initially identified by a genetic screen as a disruptor of telomeric silencing in Saccharomyces cerevisiae; further, it is the only known non-SET domain containing histone methyltransferase. Methylation of H3K79 is involved in the regulation of telomeric silencing, cellular development, cell-cycle checkpoint, DNA repair, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
104
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 146 publications
(107 citation statements)
references
References 88 publications
2
104
0
1
Order By: Relevance
“…Methylation of H3K79 is involved in the regulation of telomeric silencing, cellular development, cell-cycle checkpoint, DNA repair, and regulation of transcription [39, 40]. Several studies show that DOT1L is a critical regulator of the cell cycle [41, 42].…”
Section: Discussionmentioning
confidence: 99%
“…Methylation of H3K79 is involved in the regulation of telomeric silencing, cellular development, cell-cycle checkpoint, DNA repair, and regulation of transcription [39, 40]. Several studies show that DOT1L is a critical regulator of the cell cycle [41, 42].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, non-Pol-II TSS show absence of H3K36me3 and H3K79me2 signals (Supplementary Figure 4). H3K36 histone modification marks are enriched on the gene body region and play important roles in transcriptional activation [29] while H3K79me2 marks have been shown to be strongly correlated with gene activity [30]. Our data suggest that the enrichment observed for H3K36me3 and H3K79me2 are specific to Pol-II transcripts (Supplementary Figure 4).…”
Section: Classification Of Tss Into Pol II and Non-pol Ii Tssmentioning
confidence: 53%
“…The adenosine derivative ( 29 ) and its phenylurea analog ( 31 ) (EPZ004777) [101] showed very good inhibition and specificity for DOT1L, reduced leukemia-relevant gene expression and induced differentiation of MLL (mixed-lineage leukemia) leukemia cells. DOT1L is the only non-SET domain HKMT and it is the only enzyme responsible for mono-, di- and trimethylation of H3K79, leading to transcriptional activation of certain oncogenes [102,103,104,105,106,107]. It is mainly involved in myeloid lymphoid leukemia with MLL rearrangements by favoring transcription of HOX (subset of homeotic genes) and MEIS (Meis homeobox 1) genes involved in acute leukemia development [105,106,108].…”
Section: Inhibition Of Histone Methylationmentioning
confidence: 99%
“…DOT1L is the only non-SET domain HKMT and it is the only enzyme responsible for mono-, di- and trimethylation of H3K79, leading to transcriptional activation of certain oncogenes [102,103,104,105,106,107]. It is mainly involved in myeloid lymphoid leukemia with MLL rearrangements by favoring transcription of HOX (subset of homeotic genes) and MEIS (Meis homeobox 1) genes involved in acute leukemia development [105,106,108]. Therefore, medicinal chemistry efforts for DOT1L inhibition have led to the first HMTi in clinics, compound ( 29 ) that completed phase I clinical trials for leukemia treatment and myelodysplastic syndromes (NCT02141828, NCT01684150).…”
Section: Inhibition Of Histone Methylationmentioning
confidence: 99%